|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008677,
umls-concept:C0008809,
umls-concept:C0030705,
umls-concept:C0087111,
umls-concept:C0150099,
umls-concept:C0205178,
umls-concept:C0279516,
umls-concept:C0439234,
umls-concept:C1707455,
umls-concept:C1719822,
umls-concept:C1947933
|
|
pubmed:issue |
5 Pt 1
|
|
pubmed:dateCreated |
2000-1-18
|
|
pubmed:abstractText |
To undertake a 1-year prospective economic evaluation of ciprofloxacin compared with usual antibacterial care (any antibacterial other than a quinolone) for the treatment of acute exacerbations of chronic bronchitis (AECB) in adults presenting with a type I or type II AECB.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
T
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1170-7690
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
499-520
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10662396-Adult,
pubmed-meshheading:10662396-Anti-Infective Agents,
pubmed-meshheading:10662396-Bronchitis,
pubmed-meshheading:10662396-Canada,
pubmed-meshheading:10662396-Chronic Disease,
pubmed-meshheading:10662396-Ciprofloxacin,
pubmed-meshheading:10662396-Cost-Benefit Analysis,
pubmed-meshheading:10662396-Economics, Pharmaceutical,
pubmed-meshheading:10662396-Female,
pubmed-meshheading:10662396-Humans,
pubmed-meshheading:10662396-Male,
pubmed-meshheading:10662396-Prospective Studies,
pubmed-meshheading:10662396-Quality-Adjusted Life Years,
pubmed-meshheading:10662396-Severity of Illness Index
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Economic evaluation of ciprofloxacin compared with usual antibacterial care for the treatment of acute exacerbations of chronic bronchitis in patients followed for 1 year.
|
|
pubmed:affiliation |
Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, Ontario, Canada.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
